A method of treating disease reiter

 

(57) Abstract:

The use of medicine, infectious diseases with an autoimmune response. Goal: increase the effectiveness of treatment, reduction of relapse. The essence of the invention: first, the patient is prescribed pyrogens after 1 - 2 days simultaneously with drugs groups of metronidazole and/or quinolones daily for 3 - 6 months, depending on the severity of the disease. Then make a break for 5 to 7 days, after which rocephin is injected together with Autocraft through day course 2 - 6 weeks. After the second 7 - 8-day interval re-assign pyrogenes under the old scheme simultaneously with the daily intake of tetracycline, course 2 - 3 weeks. In addition, patients prescribed symptomatic treatment.

The invention relates to medicine, namely to infectious diseases with an autoimmune response, and can be used to treat the disease Reuter (BR).

There is a method of BR treatment with antibiotics, such as tetracycline, in combination with local therapy urogenitale the infection detoxification and desensibilisation means, nonsteroidal anti-inflammatory drugs (phenylbutazone, reopirin and so on). In addition, in the second stage BR nkawie urethritis in men M., Medicine, 1990, S. 271).

The prototype disadvantages: frequent (3-4 times per year) relapses, disability.

The invention is directed to solving objectives: increase the effectiveness of treatment, reduction of relapse.

The task is achieved by the new scheme of treatment BR.

First, the patient is prescribed pyrogens after 1 - 2 days with drugs groups of metronidazole and/or quinolones daily for 3 - 6 months depending on the severity of the disease. Then make a break for 5 to 7 days, after which rocephin is injected simultaneously with autohemotherapy through day course 2 - 6 weeks. Then make a break for 7 - 8 days and re-assign pyrogenes under the old scheme simultaneously with the daily intake of tetracycline, course 2 - 3 weeks. In addition, patients prescribed symptomatic treatment.

The method is as follows.

The patient intramuscularly injected pyrogens at a dose of 10 MGK on increasing depending on the reaction (up to t body 37,0 - 37,5oC) after 1 - 2 days and drugs groups of metronidazole and/or quinolones, for example trichopol in a dose of 0.25 x 2 daily for 3 - 6 months. Then make a break for 5 to 7 days, after which the patient intramuscularly in the VA make a break 7 - 8 days and re-enter pyrogenes under the old scheme simultaneously with tetracyclines, for example, vibramicina, which is prescribed daily therapeutic dose, treatment 2 to 3 weeks.

In addition, if necessary, the patient is prescribed symptomatic treatment: sykorova, sulcotrione, ibuprofen, vitamins, antihistamines: rumalon, oxygen; exercise therapy, manual therapy, hydrogen sulfide baths, etc.

An example of a specific implementation.

Example 1. Patient Saint. 24, was admitted with a diagnosis of the disease Reiter (rnga 1:120), reactive arthritis knee, ankle, and interphalangeal joints of the feet. Infertility II Art.

Patient assigned: pyrogenes 10 MGK through day for 3 months, metrogylum 0.25 twice a day, 5 NOK 2 tablets 4 times a day, exercise therapy, manual therapy, after 5 days of break were introduced rocephin 4 g plus 3 ml of autologous blood in the same syringe every other day for 2 weeks. Then after the second 7-day interval was again introduced pyrogenes through the day with 10 SCC with vibramicina 0.1 daily for 3 weeks. After the treatment has no pain, swelling in the joints (rnga 1:40). The patient recovered. After 3 months pregnant, gave birth to a boy (rnga 1:20). REC: 80), aphonia, hepatitis b and C in the subacute stage. Treatment: pyrogenes 10 MGK through the day, flagyl 0.25 twice a day every day, norbactin 0.4 per day, exercise therapy, manual therapy through the day. Through 14 weeks after hypothermia has pain and swelling in the knee joints (rnga 1: 160). Treatment supplemented with ibuprofen 0.25 three times a day for 3 weeks, sykorova N3. Break 7 days, then continued treatment with rozenom 6 g plus 5 ml of autologous blood in the same syringe every other day for 2 weeks. After the second 8-day break patient newly appointed pyrogenes 10 MGK through the day together with APO-doxy 0.1 daily for 2 weeks. The patient recovered, the volume of the voice has fully recovered. Recurrence arthritis no rnga 1:40).

Example 3. Patient CH. 35 years old, was admitted with a diagnosis of a disease Reiter, bilateral sacroiliac, atrophy of the muscles of the deltoid, trapezius of the shoulder joint, piriformis and gluteus in the field of hip joints, osteoporosis of the femoral head to the right and left shoulder bones (rnga 1:80). Cachexia (weight at admission 37 kg).

Patient assigned: pyrogenes 10 MGK 2 days, neovir 1 ml, alternating with pyrogenal, noroxin 0.4 in the day, trichopol first and hip joints a day for 3 months sykorova N3, sulcotrione N3 conventional scheme. After 5-day break was appointed rocephin 4 mg with 5 ml of autologous blood into the same syringe through the day for 6 weeks. After the second 7-day break, the newly appointed pyrogens with 10 g in 2 days instead of randomizing 0.3 twice a day for 2 weeks. The patient recovered. Joint pain no rnga 1: 20), weight 56 kg, the Amount of movement in the joints fully restored. The effects of osteoporosis were corrected in the future with the help of 3 courses rumalon, vitreous body, osteopina and acupuncture.

The proposed method of treatment of a disease Reiter allows you to avoid recurrence of the disease, which, if known treatment there are 3 to 4 times a year, disability and completely restore the function of organs and body systems.

A method of treating disease by Reiter antibiotics and symptomatic treatment, wherein the patient intramuscularly injected pyrogens in 1 to 2 days and drugs groups of metronidazole and/or quinolones daily therapeutic doses, the course of 3 to 5 months, then after 5 to 7-day break to the patient intramuscularly, recevin in the dose of 4 to 5 g with Autocraft in the amount of 3 to 5 ml through day 2 course 6 weeks the day at therapeutic doses for 2 to 3 weeks.

 

Same patents:

The invention relates to the field of medicine, stereotactic removal of intracerebral haematomas
The invention relates to medicine, namely to otolaryngology
The invention relates to veterinary medicine, in particular, to methods of normalization of gonadotropic function in cows with the help of a medicinal product containing organic active ingredients
The invention relates to medicine, and is intended for the treatment of venous disorders and stimulation of reparative processes of the body with their injuries of different nature and different locations
The invention relates to medicine, namely to traumatology, orthopedics, Hematology, and relates to a method of preventing bleeding and Spitzweg moves and prevention allospecific hematomas in patients with bleeding disorders

The invention relates to medicine and can be used in clinical practice for early and timely detection of complications during the neonatal period
The invention relates to biology and can be used in veterinary medicine to increase immunity, growth and development of young agricultural animals
The invention relates to medicine, namely to gastroenterology and can be used in the treatment of gastric ulcer

The invention relates to medicine, namely to endocrinology, internal medicine, surgery, obstetrics and gynecology, may be used in clinical practice in the diagnosis of various diseases, as well as to identify individuals with risk factors

The invention relates to veterinary medicine, and in particular to methods of prevention of disease of young pigs
The invention relates to medicine, namely to anesthesiology
The invention relates to medicine, namely to anesthesiology

The invention relates to farming, in particular to the cultivation of downhole young foxes, and can be used in fur farms

The invention relates to medicines used in veterinary practice, and can be used in the production of veterinary drugs for the prevention and treatment of postpartum endometritis in cows
Up!